Terns Pharmaceuticals, Inc.

TERNDelisted May 5, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001831363

SEC filings (opens in a new tab)

Terns Pharmaceuticals, Inc. was delisted on May 5, 2026; its insiders filed their last Form 4 on May 5, 2026; 317 institutions reported holding it in 13F filings for Q1 2026, worth $6.56B in total; Soros Fund Management was the only superinvestor holding it.

Q1 2024 vs. Q4 2023

How the institutions holding Terns Pharmaceuticals, Inc. changed between Q4 2023 and Q1 2024.

All holders in Q1 2024 All holders in Q4 2023

13F holders of TERN: Q4 2023 compared with Q1 2024
Measure	Q4 2023	Of which not filed for Q1 2024	Q1 2024	Change
Holders	103	1	112	+10
Shares	63.6M	10.5K	63.2M	−335.1K (−0.5%)
Value	$412.7M	$67.8K	$414.8M	+$2.23M (+0.5%)

1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q1 2024 but not at the end of Q4 2023.

Institutions new to TERN in Q1 2024
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	2,221,200	$14.6M	0.04%
Octagon Capital Advisors LP	625,000	$4.10M	0.50%
Monashee Investment Management LLC	300,000	$1.97M	0.23%
Eversept Partners, LP	283,034	$1.86M	0.14%
Bridger Management, LLC	246,800	$1.62M	0.73%
Exome Asset Management LLC	227,821	$1.49M	1.28%
Marshall Wace, LLP	186,009	$1.22M	0.00%
Wellington Management Group LLP	172,599	$1.13M	0.00%
Prelude Capital Management, LLC	84,619	$555.1K	0.04%
HRT Financial LP	74,755	$490.0K	0.00%
Squarepoint Ops LLC	71,361	$468.1K	0.00%
Virtu Financial LLC	44,307	$291.0K	0.02%
Graham Capital Management, L.P.	30,231	$198.3K	0.01%
D. E. Shaw & Co., Inc.	17,790	$116.7K	0.00%
Engineers Gate Manager LP	17,266	$113.3K	0.00%
Kennedy Capital Management, Inc.	15,466	$101.5K	0.00%
Walleye Trading LLC	15,000	$98.4K	0.00%
LPL Financial LLC	14,344	$94.1K	0.00%
HSBC Holdings PLC	13,972	$91.7K	0.00%
Aquatic Capital Management LLC	1,400	$9.18K	0.00%
Stone House Investment Management, LLC	1,000	$6.56K	0.00%
Cubist Systematic Strategies, LLC	327	$2.15K	0.00%
ZRC Wealth Management, LLC	225	$1.48K	0.00%
CIBC Private Wealth Group, LLC	100	$710	0.00%
Allworth Financial LP	90	$591	0.00%
National Bank of Canada	100	$555	0.00%
Nelson, Van Denburg & Campbell Wealth Management Group, LLC	9	$59	0.00%

Sold out (17)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2023 and filed for Q1 2024 without it.

Institutions that sold out of TERN in Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Braidwell LP	2,318,050	$15.0M
Perceptive Advisors LLC	1,075,000	$6.98M
Decheng Capital LLC	714,285	$4.64M
Pale Fire Capital SE	49,014	$318.1K
Mirae Asset Global Investments Co., Ltd.	40,679	$264.0K
Belvedere Trading LLC	25,963	$168.5K
Walleye Capital LLC	25,295	$164.2K
Martingale Asset Management L P	15,469	$100.4K
Balyasny Asset Management LLC	13,854	$89.9K
State Board of Administration of Florida Retirement System	12,440	$80.7K
Brevan Howard Capital Management LP	10,842	$70.4K
Bleakley Financial Group, LLC	10,452	$67.8K
AJOVista, LLC	8,943	$58.0K
Quantbot Technologies LP	4,498	$29.2K
Fortitude Family Office, LLC	300	$1.95K
Simplex Trading, LLC	170	$1.00K
ICA Group Wealth Management, LLC	80	$519

Not filed for Q1 2024 yet (1)

Institutions that held Terns Pharmaceuticals, Inc. at the end of Q4 2023 and haven't filed a 13F for Q1 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding TERN in Q4 2023 that haven't filed for Q1 2024
Institution	Shares, Q4 2023	Value, Q4 2023
Sawtooth Solutions, LLC	10,452	$67.8K